Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Dramatic Price Increases in Brand Name Drugs Spur Shareholders to Action

April 27, 2011 By Bio-Medicine.Org

NEW YORK, April 27, 2011 /PRNewswire-USNewswire/ — As the
skyrocketing costs of brand name drugs leave millions of Americans
skipping doses or abandoning their prescriptions, investors
representing 14 faith and health care organizations are petitioning
the nation’s top pharmaceutical companies to re-examine pricing for
commonly used drugs like Lipitor, Plavix and Celebrex in an effort
to make them more affordable.

The group is citing several benchmarking reports including one
from the General Accountability Office this past February that
found branded drugs consistently outpacing generics relative to
inflation (6.3% vs. 3.8%). ICCR members are asking management for
pricing that hews closer to the consumer price index, a strategy
they believe is a more accurate reflection of value and a more
sustainable policy over the long term.

The Centers for Medicare and Medicaid Services projects that
U.S. prescription drug spending will grow 93% during 2008-2018,
exceeding all major categories of health expenditures. AARP reports
that the branded prescriptions most widely used by Medicare
patients increased 9.7%, far exceeding the cost for other consumer
goods in the last 12 months: prices for generics during the same
time period fell. A November 2010 report from Deloitte Consulting
concluded that the issue will intensify, and that current
pricing practices are not sustainable.

“The evidence from all the studies is clear,” said
Ed Gerardo, director, Community Commitment and Social Investments
of Bon Secours Health System, Inc. “Measures must be taken to
control costs and bring transparency into the drug pricing
equation.”

Resolutions are on the ballots at the nation’s top
pharmaceutical companies including Johnson and Johnson, Abbott,
Bristol-Myers Squibb and Pfizer, requesting that management
utilize a combination of approaches to keep drug prices at
reasonable levels.

ICCR members have been in

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech